SON 241220 50.00P (SON241220P50000) Stock Options, News & Quotes

0.30
-0.02-6.25%

15min DelayClose Nov 27 16:00 ET

0.35High0.30Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo AI

Dec 4, 2023 05:01

Despite recent insider selling at Sonoco Products, shareholders need not worry deeply as insiders retain considerable company ownership, suggesting alignment with shareholders. Notably, the buying activity over the past year signals insider enthusiasm.

One Sonoco Products Insider Raised Stake By 99% In Previous Year

Moomoo AI

Oct 31, 2023 08:54

Sonoco's decent ROE comes with high debt levels, indicating risk. High ROEs without excessive debt denote good quality. Among companies with similar debt-to-equity ratios, a higher ROE is preferable.

Did Sonoco Products Company (NYSE:SON) Use Debt To Deliver Its ROE Of 21%?

Mooers Radar

Feb 7, 2023 18:48

Columns US Top Gap Ups and Downs on 2/7: OSH, BIDU, PSO, CHWY and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Oak Street Health (OSH.US)$ -up 26.6%
2. $Baidu (BIDU.US)$ -up 7.5%
3. $BP PLC (BP.US)$ -up 3.2%
4. $Fiserv (FISV.US)$ -up 2.4%
5. $Mitsubishi UFJ Financial Group (MUFG.US)$ -up 1.4%
6. $GlaxoSmithKline (GSK.US)$ -up 0.8%
7. $Microsoft (MSFT.US)$ -up 0.7%
8. $Sanofi (SNY.US)$ -up 0.5%
9. $Activision Blizzard (ATVI.US)$ -up 0.4%...

+15

Movers and Shakers

Oct 11, 2022 07:51

Columns Today's Pre-Market Stock Movers: AAL, ZS, DICE, Crude and More

Gapping up
In reaction to earnings/guidance:
• $New Relic (NEWR.US)$ +3.8% (guidance), $American Airlines (AAL.US)$ +2% (guidance)
Other news:
• $DICE THERAPEUTICS, INC. (DICE.US)$ +66.5% (announces "positive" topline data from its Phase 1 clinical trial of DC-806 an oral small molecule antagonist of the pro-inflammatory cytokine IL-17)
• $Albireo Pharma (ALBO.US)$ +17.2% (reports positive topline data from Phase 3 Trial of Bylvay (odevix...

Analysts Notebook

Jul 1, 2022 06:54

Columns Top upgrades and downgrades on 7/1: CMCSA, FDX, XPEV, HOG and more

Upgrades
• $Coupang (CPNG.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $19 (from $28)
• $First Republic Bank (FRC.US)$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $188 (from $210)
• $Sitio Royalties (STR.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $43 (from $36)
Downgrades
• $Duck Creek Technologies (DCT.US)$ : JMP Securities Downgrades to Market Perform from Market Outperform
•...